Telmisartan and Hydrochlorothiazide Clinical Trials

• A Randomised, Double-Blind, Placebo-Controlled, 3 x 3 Factorial Trial of Telmisartan and Hydrochlorothiazide in Patients With Essential Hypertension.
  ClinicalTrials.gov Identifier: NCT00153049 - Completed
  Hypertension
  
• A Randomized, Double-Blind, Parallel-Group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison with Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients with Mild to Modera
  ClinicalTrials.gov Identifier: NCT00133185 - Completed
  Hypertension
  
• Open-Label Trial of the Efficacy and Safety of Combination of Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg Tablets in Patients With Hypertension.
  ClinicalTrials.gov Identifier: NCT00267943 - Completed
  Hypertension
  
• A Randomized, Double-Blind, Placebo-Controlled, Forced-Titration, Phase IV Study Comparing Telmisartan 80 Mg + Hydrochlorothiazide 25 Mg [Micardis HCT] Versus Valsartan 160 Mg + Hydrochlorothiazide 25 Mg [Diovan HCT] Taken Orally for Eight Weeks in Patien
  ClinicalTrials.gov Identifier: NCT00168779 - Completed
  Hypertension
  
• Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine
  ClinicalTrials.gov Identifier: NCT00509470 - Recruiting
  Essential Hypertension
  
• A Randomised, Double-Blind Study Comparing a Fixed Dose Combination of Telmisartan 40 Mg Plus Hydrochlorothiazide 12.5 Mg to Telmisartan 40 Mg (Micardis®) in Patients Who Fail to Respond Adequately to Treatment with Telmisartan (Micardis®) 40 Mg
  ClinicalTrials.gov Identifier: NCT00144222 - Completed
  Hypertension
  
• ONTARGET: ONgoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Tria Parallel Trial. TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects with Cardiovascular Disease Trial.
  ClinicalTrials.gov Identifier: NCT00153101 - Active, not recruiting
  Cardiovascular Diseases
  
• Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults
  ClinicalTrials.gov Identifier: NCT00439738 - Active, not recruiting
  Hypertension
  
• A Comparison of Telmisartan 80 mg + Hydrochlorothiazide 12.5 mg With Amlodipine 10 mg + Hydrochlorothiazide 12.5 mg in the Control of Blood Pressure in Older Patients With Predominantly Systolic Hypertension. A Prospective, Randomised, Open-Label, Blinded
  ClinicalTrials.gov Identifier: NCT00240474 - Completed
  Hypertension
  
• An Eight Week Randomized, Double-Blind, Double-Dummy Study Comparing a Fixed Dose Combination of Telmisartan 80mg Plus Hydrochlothiazide 12.5mg to Telmisartan 80mg in Patients Who Fail to Respond Adequately to Treatment With Telmisartan 80mg
  ClinicalTrials.gov Identifier: NCT00146341 - Completed
  Hypertension
  
• Efficacy of Valsartan/Hydrochlorothiazide Versus Amlodipine and Hydrochlorothiazide in Patients Hypertension
  ClinicalTrials.gov Identifier: NCT00425997 - Active, not recruiting
  Hypertension
  
• Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial
  ClinicalTrials.gov Identifier: NCT00147264 - Active, not recruiting
  Metabolic Syndrome X
  
• Safety/Efficacy of Combo Therapy With Aliskiren & Hydrochlorothiazide vs Therapy With Hydrochlorothiazide Alone in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00387517 - Active, not recruiting
  Hypertension
  
• Efficacy of Irbesartan/Hydrochlorothiazide Versus Valsartan/Hydrochlorothiazide in Mild to Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00500604 - Recruiting
  Hypertension
  
• Telmisartan/Amlodipine (80/5) vs. Telmisartan/Amlodipine (40/5) vs. Amlodipine 10 or 5 in Resistant Hypertension
  ClinicalTrials.gov Identifier: NCT00558428 - Recruiting
  Hypertension
  
• Telmisartan/Amlodipine (80/10) vs. Telmisartan/Amlodipine (40/10) vs. amlodipine10 in Resistant Hypertension
  ClinicalTrials.gov Identifier: NCT00553267 - Recruiting
  Hypertension
  
• A Randomised, Double-Blind, Placebo-Controlled, Multicenter Trial to Investigate the Preventive Effect of BIBR277 (Telmisartan (Micardis®, Gliosartan®, Kinzal®, Kinzalmono®, Predxal®, Pritor®, Samertan®, Telmisartan®
  ClinicalTrials.gov Identifier: NCT00153088 - Completed
  Diabetic Nephropathies
  
• Safety and Efficacy of Valsartan Plus Hydrochlorothiazide and Amlodipine in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00426478 - Active, not recruiting
  Hypertension
  
• Antihypertensive Effectiveness of the Associations of Hydrochlorothiazide and Amiloride and Hydrochlorothiazide and Enalapril
  ClinicalTrials.gov Identifier: NCT00394394 - Completed
  Hypertension
  
• The Real-Life Efficacy and Safety of Telmisartan in Patients With Arterial Hypertension
  ClinicalTrials.gov Identifier: NCT00471003 - Active, not recruiting
  Hypertension
  
• Combination of Telmisartan and Simvastatin in the Treatment of Hypertension and Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00316095 - Active, not recruiting
  Hypertension; Dyslipidemias
  
• Compliance With Antihypertensive Telmisartan Therapy (COAST)
  ClinicalTrials.gov Identifier: NCT00470886 - Recruiting
  Hypertension
  
• Filtered Trial for Telmisartan 40mg Non-Responder
  ClinicalTrials.gov Identifier: NCT00550953 - Recruiting
  Hypertension
  
• Safety and Efficacy of Valsartan Versus Atenolol and Hydrochlorothiazide Combination on Blood Flow in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00396656 - Active, not recruiting
  Hypertension
  
• Double-Blind Randomized Cross-Over Trial Comparing Metabolic Effects of Candesartan, Hydrochlorothiazide and Placebo
  ClinicalTrials.gov Identifier: NCT00282178 - Active, not recruiting
  Hypertension; Obesity
  
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00277472 - Active, not recruiting
  Hypertension
  
• Efficacy and Safety of Valsartan/Hydrochlorothiazide Combination Therapy in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00280540 - Active, not recruiting
  Hypertension
  
• Efficacy and Safety of Valsartan, Hydrochlorothiazide and Amlodipine Combination Therapy in Hypertension
  ClinicalTrials.gov Identifier: NCT00400777 - Active, not recruiting
  Hypertension
  
• Observational Non-Interventional Study (Anwendungsbeobachtung) With Telmisartan in High-Risk Hypertensives
  ClinicalTrials.gov Identifier: NCT00539487 - Recruiting
  Hypertension; Obesity
  
• PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes
  ClinicalTrials.gov Identifier: NCT00153062 - Active, not recruiting
  Cerebrovascular Accident
  
• A Clinical Study to Evaluate the Long-Term Safety (12 Months) of the Combination of Aliskiren 300 mg and Hydrochlorothiazide 25 mg
  ClinicalTrials.gov Identifier: NCT00171405 - Active, not recruiting
  Hypertension
  
• A Clinical Study to Evaluate Safety & Efficacy of the Combination of Aliskiren, Valsartan & Hydrochlorothiazide in Diabetic Hypertensive Nonresponder Patients
  ClinicalTrials.gov Identifier: NCT00219102 - Active, not recruiting
  Hypertension; Diabetes
  
• Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Fixed Dose Combination in Hypertensive Patients Not Controlled by the Free Combination of an Angiotensin Receptor Blocker Plus Hydrochlorothiazide
  ClinicalTrials.gov Identifier: NCT00360178 - Completed
  Hypertension
  
• Telmisartan vs. valsartan missed dose
  ClinicalTrials.gov Identifier: NCT00034840 - Completed
  Hypertension
  
• Irbesartan/Hydrochlorothiazide National Taiwan University Hospital Listing
  ClinicalTrials.gov Identifier: NCT00443612 - Recruiting
  Hypertension
  
• Effects of ROSIglitazone on Inflammatory Markers and Adipokines in Diabetic Patients Using an Angiotensin Receptor Blocker (TELmisartan) – The ROSITEL Study
  ClinicalTrials.gov Identifier: NCT00486187 - Recruiting
  Type 2 Diabetes Mellitus
  
• Effectiveness of Candesartan and Telmisartan on Morning Hypertension in Japanese Obese Patients
  ClinicalTrials.gov Identifier: NCT00288717 - Recruiting
  Hypertension
  
• Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00281580 - Recruiting
  Hypertension
  
• Pharmacodynamic Influences of Candesartan, Atenolol, Hydrochlorothiazide and Drug Combinations in Hypertensive Patients.
  ClinicalTrials.gov Identifier: NCT00232882 - Recruiting
  Hypertension
  
• A Prospective, Randomised, Double-Blind, Double-Dummy, Forced-Titration, Multicentre, Parallel Group, One Year Treatment Trial to Compare Telmisartan (MICARDIS) 80 mg Versus Losartan (COZAAR) 100 mg, in Hypertensive Type 2 Diabetic Patients With Overt Nep
  ClinicalTrials.gov Identifier: NCT00168857 - Active, not recruiting
  Hypertension; Diabetic Nephropathies
  
• A Safety and Tolerability Study of the Combination of Aliskiren/Valsartan in Patients With High Blood Pressure, Followed by Long-Term Safety and Tolerability of Aliskiren, Valsartan and Hydrochlorothiazide.
  ClinicalTrials.gov Identifier: NCT00386607 - Active, not recruiting
  Hypertension
  
• A 16 Week Study to Evaluate the Effect on Insulin Sensitivity of Valsartan (320 mg) and Hydrochlorothiazide (25 mg) Combined and Alone, in Patients With Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00170937 - Active, not recruiting
  Metabolic Syndrome; Hypertension; Pre-Hypertension
  
• Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy
  ClinicalTrials.gov Identifier: NCT00446563 - Active, not recruiting
  Hypertension; Hypertrophy, Left Ventricular
  
• Regulation of Inflammatory Parameters by Telmisartan in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00560430 - Not yet recruiting
  Hypertension; Metabolic Syndrome; Hypertriglyceridemia
  
• Pharmacokinetic Drug Interaction Study Following co-Administration of Valsartan, Hydrochlorothiazide and Amlodipine in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00548067 - Recruiting
  Hypertension
  
• Efficacy of the New Closure Device in Improving Patient Compliance in Treatment of Hypertension With Valsartan+/-Hydrochlorothiazide (HCTZ) at 6 Months
  ClinicalTrials.gov Identifier: NCT00487123 - Recruiting
  Hypertension
  
• The Vascular Effects of Carvedilol CR + Lisinopril Versus Lisinopril + Hydrochlorothiazide in Abdominally Obese Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00459056 - Recruiting
  Abdominal Obesity; Hypertension
  
• Telmisartan and Renal Perfusion in Patients With Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00452192 - Recruiting
  Metabolic Syndrome
  
• Trial of Telmisartan 80mg/HCTZ 12.5mg and Telmisartan 40mg/HCTZ 12.5mg in Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00326768 - Completed
  Hypertension
  
• Losartan vs. Hydrochlorothiazide in Reversing Remodeling of Small Arteries in Pre-Hypertensive Pre-Diabetic Subjects
  ClinicalTrials.gov Identifier: NCT00388388 - Recruiting
  Pre-Hypertension; Pre-Diabetes
  
• A Prospective, Randomised, Double-Blind, Double-Dummy, Forced-Titration, Multicentre, Parallel Group, One Year Treatment Trial to Investigate the Efficacy of Telmisartan 80 Mg Versus Valsartan 160 Mg in Hypertensive Type 2 Diabetic Patients with Overt Nep
  ClinicalTrials.gov Identifier: NCT00153023 - Completed
  Diabetic Nephropathies; Hypertension
  
• A Randomized, Double-Blind, Active Control Trial Comparing Effects of Telmisartan, Candesartan and Amlodipine, Alone or Plus Metformin, on Non-Diabetic, Obese Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00538486 - Not yet recruiting
  Hypertension; Obesity
  
• Hydrochlorothiazide (+) Losartan Potassium Vs. Amlodipine Comparative Study
  ClinicalTrials.gov Identifier: NCT00157963 - Completed
  Essential Hypertension
  
• Effect of the Known Antihypertensive Drug Telmisartan on Red Blood Cells and Circulation in the Smallest Blood Vessels
  ClinicalTrials.gov Identifier: NCT00559286 - Not yet recruiting
  Arterial Hypertension; Diabetes Mellitus Type 2 IRC or NIR
  
• Treatment of Insulin Resistance in Hypertensive, Obese Adolescents
  ClinicalTrials.gov Identifier: NCT00185705 - Recruiting
  Hypertension; Insulin Resistance; Dyslipidemia
  
• Olmesartan Alone or in Combination With Hydrochlorothiazide in Subjects With Mild to Moderate Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00139698 - Completed
  Essential Hypertension
  
• Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00430508 - Not yet recruiting
  Essential Hypertension
  
• Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00430950 - Not yet recruiting
  Essential Hypertension
  
• Telmisartan and Losartan in Hypertensive IGT
  ClinicalTrials.gov Identifier: NCT00407862 - Completed
  Hypertension; Impaired Glucose Tolerance
  
• Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)
  ClinicalTrials.gov Identifier: NCT00263393 - Recruiting
  * Myocardial Infarction; Angina Pectoris; Cerebrovascular Accidents; Diabetes Mellitus
  
• PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
  ClinicalTrials.gov Identifier: NCT00274599 - Completed
  Hypertension
  
• An Open Label Study to Assess the Efficacy, Safety and Tolerability of COZAAR Plus (Losartan Potassium 50mg/Hydrochlorothiazide 12.5mg) Possibly Titrated up to COZAAR Plus-F (Losartan Potassium 100mg/Hydrochlorothiazide 25mg) in Patients With Essential Hy
  ClinicalTrials.gov Identifier: NCT00449111 - Terminated
  Hypertension
  
• DETAIL Study: Diabetes Exposed to Telmisartan and Enalapril
  ClinicalTrials.gov Identifier: NCT00274118 - Completed
  Hypertension; Diabetes Mellitus, Type 2
  
• Telmisartan (Micardis) and Ramipril (Altace) - Factorial Design Study for the Treatment of Hypertension
  ClinicalTrials.gov Identifier: NCT00281593 - Completed
  Hypertension
  
• A Randomized, Double-Blind, Placebo Controlled Comparison of Telmisartan HCT and Valsartan HCT in HTN Stage I/II Patient
  ClinicalTrials.gov Identifier: NCT00240448 - Completed
  Hypertension
  
• Avoiding Cardiovascular Events through Combination therapy in patients with Systolic Hypertension ACCOMPLISH
  ClinicalTrials.gov Identifier: NCT00097864 - No longer recruiting
  Heart Disease
  
• Valsartan/Hydrochlorothiazide Combination vs Amlodipine in Patients With Hypertension, Diabetes, and Albuminuria.
  ClinicalTrials.gov Identifier: NCT00171561 - Completed
  Hypertension
  
• Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan Alone
  ClinicalTrials.gov Identifier: NCT00170989 - Completed
  Hypertension
  
• Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00355589 - Completed
  Hypertension; Blood Pressure, High
  
• Combination of Benazepril Plus Hydrochlorothiazide in Chinese Patients With Mild to Moderate Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00367094 - Completed
  Hypertension
  
• Long Term Safety of Aliskiren Alone or With the Optional Addition of Hydrochlorothiazide in Patients With Essential Hypertension
  ClinicalTrials.gov Identifier: NCT00219037 - Completed
  Hypertension
  
• A Study Comparing Valsartan With And Without Hydrochlorothiazide In Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00241007 - Completed
  Hypertension
  
• Valsartan/Hydrochlorothiazide Combination in the Treatment of Severe Hypertension
  ClinicalTrials.gov Identifier: NCT00273299 - Completed
  Hypertension
  
• Clinical Study to Evaluate the Efficacy and Safety of Aliskiren Alone and in Combination With Hydrochlorothiazide in Patients With Essential Hypertension.
  ClinicalTrials.gov Identifier: NCT00219024 - Completed
  Hypertension
  
• Higher Dose of Ramipril Versus Addition of Telmisartan-Ramipril in Hypertension and Diabetes
  ClinicalTrials.gov Identifier: NCT00208221 - Terminated
  Hypertension; Type 2 Diabetes; Microalbuminuria
  
• Telmisartan in Haemodialysis Patients With Chronic Heart Failure
  ClinicalTrials.gov Identifier: NCT00490958 - Completed
  Heart Failure, Congestive
  
• PROBE Parallel 6-wk Treatment Comparing Telmisartan/HCT (40/12.5 or 80/12.5) With Losartan/HCT (50/12.5) Using ABPM
  ClinicalTrials.gov Identifier: NCT00274638 - Completed
  Hypertension
  
• Outcome Study ONTARGET
  ClinicalTrials.gov Identifier: NCT00034931 - No longer recruiting
  Coronary Disease; Angina Pectoris; Cerebrovascular Accident; Myocardial Infarction
  
• A Clinical Study to Compare Long-Term Efficacy and Safety of an Aliskiren Based Regimen to a Hydrochlorothiazide Based Treatment Regimen With Optional Addition of Amlodipine
  ClinicalTrials.gov Identifier: NCT00294710 - Completed
  Hypertension
  
• Treatment of High Blood Pressure Using Olmesartan with Hydrochlorothiazide Compared to an ACE Inhibitor with a Calcium Channel Blocker
  ClinicalTrials.gov Identifier: NCT00185120 - Completed
  Hypertension
  
• A Prospective, Randomized, Double-Blind, Double-Dummy, Forced Titration, Parallel Group Comparison, Multicenter Trial to Compare the Effects of Either Telmisartan (40-80 mg p.o. Once Daily) or Ramipril (5-10 mg p.o. Once Daily) on Renal Endothelial Dysfun
  ClinicalTrials.gov Identifier: NCT00240422 - Completed
  Diabetes Mellitus, Type 2; Hypertension
  
• Irbesartan/Hydrochlorothiazide and Irbesartan in the Treatment of Mild to Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00263003 - Completed
  Hypertension
  
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
  ClinicalTrials.gov Identifier: NCT00095394 - Completed
  Hypertension
  
• Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy for Patients with Moderate Hypertension
  ClinicalTrials.gov Identifier: NCT00095550 - Completed
  Hypertension
  
• A Safety and Efficacy Trial of the Combination of Aliskiren / Hydrochlorothiazide (HCTZ)(300/12.5 mg and 300/25 mg) Compared to Aliskiren 300 mg in Hypertensive Patients
  ClinicalTrials.gov Identifier: NCT00386139 - Completed
  Hypertension
  
• The Primary Objective of This Study is to Determine Whether MICARDIS® Improves Insulin Sensitivity in Overweight or Obese, Non-Diabetic, Normotensive Subjects.
  ClinicalTrials.gov Identifier: NCT00146289 - Completed
  Indication 1:Obesity; Indication 2:Insulin Resistance
  
• Olmesartan as an Add-on to Amlodipine in Hypertension
  ClinicalTrials.gov Identifier: NCT00220233 - Completed
  Essential Hypertension
  
• Irbesartan in the Treatment of Hypertensive Patients with Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00110422 - Completed
  Metabolic Syndrome X; Hypertension
  
• Diuretics, Hypertension, and Arrhythmias Clinical Trial
  ClinicalTrials.gov Identifier: NCT00000525 - Completed
  Cardiovascular Diseases; Death, Sudden, Cardiac; Heart Arrest; Heart Diseases; Hypertension